Search
for
Sort by
Research 31–60 of 1000+
- NEURONAL MIMICRY AS A RESISTANCE PHENOTYPE IN CANCER CELLS
- The Effect of Finasteride on the Expression of Vascular Endothelial Growth Factor and Microvessel Density: A Possible Mechanism for Decreased Prostatic Bleeding in Treated Patients
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents.
- Glatze in jungen Jahren könnte Risikofaktor für BPH sein
- Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician
- What do we know about phytotherapy of benign prostatic hyperplasia?
- The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
- Is dehydroepiandrosterone a hormone?
- Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- The PDGF/PDGFR pathway as a drug target
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- Androgen receptors and their biology
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Significance of the polyglutamine tract polymorphism in the androgen receptor
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period
- The Latest Advance in Hair Regeneration Therapy Using Proteins Secreted by Adipose-Derived Stem Cells
- Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer
- Estimating the Contribution of the Prostate to Blood Dihydrotestosterone
- Androgen Receptor Mutations and Polymorphisms in African American Prostate Cancer
- The pathophysiology of delayed ejaculation
- Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men
- Androgen Receptor in Human Health: A Potential Therapeutic Target